Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi to Launch Microarray Contract Service with Agilent Arrays

NEW YORK, July 25-Hitachi Life Science will use Agilent microarrays and equipment to create a contract research service for Japanese pharmaceutical companies, Agilent said today.

 

Hitachi plans to open a service center later this month for Japanese companies interested in researching gene expression as it relates to human disease.

 

The service will use custom and standard Agilent microarrays for human, mouse and rat. Previously, Hitachi relied upon its own in-house microarrays.

 

The companies did not reveal financial specifics of the arrangement.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.